Document Detail


How do Compliance, Convenience, and Tolerability Affect Blood Pressure Goal Rates?
MedLine Citation:
PMID:  22920049     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Uncontrolled hypertension imposes a substantial global health burden, and poor patient compliance with prescribed antihypertensive medication makes a major contribution to the development of suboptimal blood pressure (BP) control. The asymptomatic nature of hypertension, side effects of medication, treatment complexity, and high pill burdens all have a negative impact on patient compliance. It is important to address the issue of poor patient compliance as studies have shown that good compliance is associated with improvement of BP control and positive health outcomes. As the majority of hypertensive patients require treatment with two or more agents to achieve goal BP, treatment guidelines have acknowledged the value of simplifying treatment through the use of fixed-dose combination (FDC) therapy. Triple FDC therapy comprising an angiotensin II type 1 receptor antagonist (angiotensin receptor blocker), calcium channel blocker, and thiazide diuretic is a novel treatment strategy for the improvement of BP control in hard-to-treat patients.
Authors:
Serap Erdine
Related Documents :
4053309 - Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilatio...
14758949 - Cessation of chronic hypertension after posterior fossa decompression in a child with c...
1789939 - Predictors of blood pressure and hypertension. general principles.
20638709 - The relationship between particulate air pollution and emergency hospital visits for hy...
8417399 - Hypertension in infancy.
20642829 - Complementary and alternative medicine in the management of hypertension in an urban ni...
11098759 - Renal physiology. laparoscopic considerations.
709449 - Postural hypotension and diuretic therapy in the elderly.
17702939 - Deep ultraviolet light-emitting hexagonal boron nitride synthesized at atmospheric pres...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-27
Journal Detail:
Title:  American journal of cardiovascular drugs : drugs, devices, and other interventions     Volume:  -     ISSN:  1179-187X     ISO Abbreviation:  Am J Cardiovasc Drugs     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100967755     Medline TA:  Am J Cardiovasc Drugs     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Cardiology, Cerrahpaşa School of Medicine, Istanbul University, Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients ...
Next Document:  Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics.